Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
31
CTXR Quote, Financials, Valuation and Earnings
Last price:
$1.61
Seasonality move
:
-26.14%
Day range:
$1.42 - $1.66
52-week range:
$0.65 - $26.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.25x
Volume:
1.4M
Avg. volume:
5.2M
1-year change:
-92.99%
Market cap:
$15.3M
Revenue:
--
EPS (TTM):
-$5.79
Earnings Data
Next earnings date for CTXR
Aug 12
2025
Most recent earnings per share
-$1.27
Missed by $1.38
(May 14/2025)
Consensus Estimate
$0.11
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CTXR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $5.8M | -- | -- | $0.33 | -- |
| 08/12/2025 | Q2 | $1.9M | -- | -- | -$0.21 | -- |
| 05/14/2025 | Q1 | -- | -- | -$1.27 | $0.11 | -$1.38 |
| 02/14/2025 | Q4 | -- | -- | -$1.30 | -$1.25 | -$0.05 |
| 12/27/2024 | Q3 | -- | -- | -$1.72 | -$1.50 | -$0.22 |
| 08/12/2024 | Q2 | -- | -- | -$1.50 | -$1.13 | -$0.38 |
| 05/14/2024 | Q1 | -- | -- | -$1.34 | -$1.50 | $0.16 |
| 02/14/2024 | Q4 | -- | -- | -$1.45 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$1.82 | -$1.50 | -$0.32 |
| 08/14/2023 | Q2 | -- | -- | -$1.50 | -$1.75 | $0.25 |
| 05/12/2023 | Q1 | -- | -- | -$1.75 | -- | -- |
| 02/10/2023 | Q4 | -- | -- | -$0.50 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$1.25 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$1.50 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$1.25 | -- | -- |
| 02/10/2022 | Q4 | -- | -- | -$1.50 | -- | -- |
| 12/16/2021 | Q3 | -- | -- | -$0.75 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$1.25 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$1.00 | -- | -- |
| 02/11/2021 | Q4 | -- | -- | -$3.75 | -- | -- |
| 12/16/2020 | Q3 | -- | -- | -$1.75 | -- | -- |
| 08/14/2020 | Q2 | -- | -- | -$2.75 | -- | -- |
| 05/14/2020 | Q1 | -- | -- | -$3.25 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$3.75 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$4.00 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$5.00 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$5.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$5.50 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$4.50 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$4.75 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$11.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$9.50 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$10.50 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$12.00 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$13.75 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$11.00 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$12.75 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$18.75 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$7.50 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$15.00 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$11.75 | -- | -- |
Citius Pharmaceuticals Earnings Questions
-
How Much did Citius Pharmaceuticals Generate in Revenue Last Quarter?
Citius Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Citius Pharmaceuticals Beat Earnings Last Quarter?
Citius Pharmaceuticals announced earnings per share of -$1.27 which represents a miss of analyst forecast a $0.11 per share.
-
Is Citius Pharmaceuticals Profitable?
Citius Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Citius Pharmaceuticals EPS Next Year?
Citius Pharmaceuticals's earnings are forecast to decrease from -$5.97 per share to -$5.63 per share next year representing a decrease of -77.47%.
-
When is Citius Pharmaceuticals's Earnings Date?
Citius Pharmaceuticals's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
